AIMS assessment
Also written as: AIMS — Abnormal Involuntary Movement Scale
Abnormal Involuntary Movement Scale used to detect and monitor tardive dyskinesia in patients receiving antipsychotic medications.
Full Definition
The Abnormal Involuntary Movement Scale (AIMS) is a standardized 12-item rating instrument used to assess involuntary movements that may develop as a side effect of antipsychotic medication treatment. The assessment examines facial expressions, extremity movements, and trunk movements on a scale from 0 to 4. Regular AIMS assessments are required for patients on long-term antipsychotic therapy as part of medication monitoring protocols. Documentation must include baseline assessments and periodic reassessments to track any emergence or progression of movement disorders.
Usage
Usage note: Always capitalize as AIMS when using the acronym. Include assessment date and scorer in documentation.
In Context
- "The quarterly AIMS assessment revealed no significant involuntary movements at this time." — Medication monitoring report
- "Baseline AIMS assessment must be completed prior to initiating antipsychotic therapy." — Clinical protocol